Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging
Marc Sirol(Université Paris Cité), Zahi A. Fayad(Icahn School of Medicine at Mount Sinai), Juan Gilberto S. Aguinaldo(Cardiovascular Institute of the South), Jean‐François Toussaint(Université Paris Cité), И. А. Черешнев, Robert M. Weisskoff(Lexington Medical Center), Valentı́n Fuster(Mount Sinai Hospital), John T. Fallon(University of Limerick), Gabor Mizsei(Cardiovascular Institute of the South), Randy Lauffer(Epix Pharmaceuticals (United States)), Philip B. Graham(Epix Pharmaceuticals (United States)), Ernane D. Reis(Icahn School of Medicine at Mount Sinai)
Cited by 76
Related Papers
Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols
|Journal of Magnetic Resonance Imaging|1999|3.1k
CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
|Radiology|2020|2.9k
Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection
|Radiology|2020|2.8k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k